Primary:96-week sustained ALT reduction.Secondary:96-week changes in AST, NAFLD, BMI, QOL scores; liver fibrosis score, steatosis score, lobular inflammation score, ballooning degradation score. This evidence concerns the gene GPT and Hepatic fibrosis.